Filter your results
- 3
- 1
- 4
- 4
- 1
- 2
- 1
- 4
- 4
- 3
- 3
- 3
- 3
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma.Cancer, 2010, 116 (4 Suppl), pp.1053-8. ⟨10.1002/cncr.24792⟩
Journal articles
hal-00930166v1
|
|||
|
Pretargeted radioimmunotherapy in rapidly progressing, metastatic, medullary thyroid cancer.Cancer, 2010, 116 (4 Suppl), pp.1118-25. ⟨10.1002/cncr.24800⟩
Journal articles
hal-00930004v1
|
||
|
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.Journal of Nuclear Medicine, 2012, 53 (8), pp.1185-92. ⟨10.2967/jnumed.111.101865⟩
Journal articles
hal-00932253v1
|
||
|
99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography.European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 (3), pp.637-43. ⟨10.1007/s00259-007-0625-9⟩
Journal articles
inserm-00520130v1
|